Trial Profile
A 24-week, prospective study to investigate the efficacy and safety of dexloxiglumide for the continuous relief of symptoms on patients with constipation-predominant irritable bowel syndrome (C-IBS)
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Jul 2005
Price :
$35
*
At a glance
- Drugs Dexloxiglumide (Primary)
- Indications Irritable bowel syndrome
- Focus Registrational; Therapeutic Use
- 12 Jul 2005 New trial record.